Picture of Shin Nippon Biomedical Laboratories logo

2395 — Shin Nippon Biomedical Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Table: Shin Nippon Biomedical - 9-MTH group results

Feb 8 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2018        Dec 31, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             12.23               11.50            15.39    
                 (+6.4 pct)          (-0.5 pct)       (-7.3 pct)  
  Operating        341 mln            loss 1.18         388 mln   
  Recurring          1.02           loss 921 mln        489 mln   
  Net                1.57             loss 1.94         816 mln   
  EPS             37.60 yen        loss 46.63 yen      19.60 yen  
  Ann Div                                NIL                      
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL                      
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T

Recent news on Shin Nippon Biomedical Laboratories

See all news